Proteomic-Based Biosignatures in Breast Cancer Classification and Prediction of Therapeutic Response

Protein-based markers that classify tumor subtypes and predict therapeutic response would be clinically useful in guiding patient treatment. We investigated the LC-MS/MS-identified protein biosignatures in 39 baseline breast cancer specimens including 28 HER2-positive and 11 triple-negative (TNBC) t...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jianbo, Whelan, Stephen A., Lu, Ming, Shen, Dejun, Chung, Debra U., Saxton, Romaine E., Faull, Kym F., Whitelegge, Julian P., Chang, Helena R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202144/
https://www.ncbi.nlm.nih.gov/pubmed/22110952
http://dx.doi.org/10.1155/2011/896476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202144/
https://www.ncbi.nlm.nih.gov/pubmed/22110952
http://dx.doi.org/10.1155/2011/896476

Ejemplares similares